Yasuo Matsueda
Director/Board Member at DELTA-FLY PHARMA, INC.
Network origin in Yasuo Matsueda first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 8 | |
Bristol-Myers Squibb KK
 Bristol-Myers Squibb KK BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb KK develops, manufactures and markets biopharmaceutical products. The company is based in Shinjuku-ku, Japan.
3
| Subsidiary | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Yasuo Matsueda via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SUMITOMO PHARMA CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| STRYKER CORPORATION | Medical Specialties | Director of Finance/CFO | |
| MANNKIND CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
GlaxoSmithKline KK
 GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan | Household/Personal Care | Director/Board Member | |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SANTEN PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Keio University | College/University | Undergraduate Degree | |
| ANGES, INC. | Pharmaceuticals: Generic | Director/Board Member | |
Taiho Pharmaceutical Co., Ltd.
 Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Sales & Marketing | |
| Muhlenberg College | College/University | Undergraduate Degree | |
| PERSEUS PROTEOMICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| TOWNNEWS-SHA CO.,LTD. | Publishing: Books/Magazines | Director/Board Member | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
IMMD, Inc.
 IMMD, Inc. BiotechnologyHealth Technology IMMD, Inc. provides drug discovery research for pharmaceutical companies. It identifies drug seeds by virtual screening, to select promising seeds and to optimize the seeds by minimum syntheses, based on estimated docking mode to the target. The firm also establishes a drug discovery method using software system for rational drug design based on 3-D structures of target proteins. Its business activities also include collaborative drug discovery researches, in-house drug discovery program, and drug seeds. The company was founded by Akiko Itai on March 16, 1995 and is headquartered in Tokyo, Japan. | Biotechnology | Corporate Officer/Principal | |
Mizuho Securities Co., Ltd.
 Mizuho Securities Co., Ltd. Investment Banks/BrokersFinance Mizuho Securities Co., Ltd. engages in the financial instruments business that includes sales and trade of equity and bond, research, and investment trusts. It operates through the following business divisions: Retail, Corporate Investment Services, and Markets and Products. The Retail business division markets equities, bonds, investment trusts, and insurance for individual clients. The Corporate Investment Services business division offers securities solutions, investment banking, management strategies and raising funds for corporate clients. The Markets and Products division handles the product development. The company was founded in July 1917 and is headquartered in Tokyo, Japan. | Investment Banks/Brokers | Corporate Officer/Principal | |
Pfizer Japan, Inc.
 Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy. | Miscellaneous Commercial Services | Director/Board Member | |
| Smithkline Beecham Seiyaku K.K. | President | ||
| Pinecrest Co., Ltd. | Director/Board Member | ||
AnGes USA, Inc.
 AnGes USA, Inc. Pharmaceuticals: MajorHealth Technology Part of AnGes, Inc., AnGes USA, Inc. develops and manufactures medicines. The company is based in Gaithersburg, MD. Ei Yamada has been the CEO of the company since 2014. | Pharmaceuticals: Major | Chief Executive Officer | |
GenomIdea, Inc.
 GenomIdea, Inc. BiotechnologyHealth Technology Part of ISHIHARA SANGYO KAISHA LTD., GenomIdea, Inc. engages in biopharmaceutical products development and distribution. The company is based in Ibaraki, Japan. GenomIdea was acquired by ISHIHARA SANGYO KAISHA LTD. from AnGes, Inc. on January 31, 2013 for $0.0 million. | Biotechnology | Director/Board Member | |
| GRAPHICO, INC. | Household/Personal Care | Director/Board Member | |
s.maX Co., Ltd.
 s.maX Co., Ltd. Medical/Nursing ServicesHealth Services s.maX Co., Ltd. provides health care services. The private company is based in Tokyo, Japan. | Medical/Nursing Services | Director/Board Member | |
Sun Pharma Japan Ltd.
 Sun Pharma Japan Ltd. Pharmaceuticals: MajorHealth Technology Part of Sun Pharmaceutical Industries Ltd., Sun Pharma Japan Ltd. is a specialty generic pharmaceutical company based in Tokyo, Japan. The Japanese company remains committed to creating long term value for its shareholders and focuses on performance and producing consistent returns. The Ministry of Corporate Affairs (MCA) notified the IEPF (Uploading of Information Regarding Unpaid and Unclaimed Amounts Lying with Companies) Rules, 2012 (IEPF Rules), which is applicable to the corporation. Information and announcements about this can be found on the company's website. The company has revenues of over US$ 4.5 billion and completed the acquisition of Ranbaxy Laboratories Limited, an international pharmaceutical company, in 2015. | Pharmaceuticals: Major | Director/Board Member | |
| VERITAS IN SILICO INC. | Biotechnology | Director/Board Member | |
| Awa Kyoudou Law Office | Corporate Officer/Principal | ||
| LBA Advisory Co., Ltd. | Director/Board Member | ||
| LBA Tax Accountant Corp. | Corporate Officer/Principal | ||
Tech & FinStrategy, Inc.
 Tech & FinStrategy, Inc. Miscellaneous Commercial ServicesCommercial Services Tech & FinStrategy, Inc. provides business consulting and plan preparation support services. The private company is based in Tokyo, Japan. | Miscellaneous Commercial Services | President | |
| IMK Life Science KK | President | ||
| Myanmar Bridge Corp. | Director/Board Member | ||
| Sachio Kishii C.P.A. office | Director/Board Member |
Statistics
International
| Japan | 27 |
| United States | 7 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 16 |
| Consumer Services | 4 |
| Consumer Non-Durables | 3 |
| Commercial Services | 3 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 29 |
| Corporate Officer/Principal | 17 |
| Independent Dir/Board Member | 7 |
| President | 4 |
| Director of Finance/CFO | 3 |
Most connected contacts
- Stock Market
- Insiders
- Yasuo Matsueda
- Company connections
